This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Valted, LLC, Johns Hopkins University. Active years: 2013-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2025
Title: **The Innovation Journey of Han Seok Ko**
Introduction
Han Seok Ko is a distinguished inventor based in Lutherville Timonium, MD, who has made significant contributions to the field of neuroscience through his innovative work. With a total of five patents, his inventions reflect his commitment to advancing medical treatments for neurological and neurodegenerative conditions.
Latest Patents
Among his latest patents, Han Seok Ko has developed a groundbreaking long-acting GLP-1 receptor agonist aimed at treating various neurological and neurodegenerative disorders. This invention relates to compositions and methods that utilize GLP-1 receptor agonists, which have been shown to exhibit neuroprotective and disease-modifying effects on the central nervous system. The implications of these patents could lead to enhanced therapeutic options for patients suffering from debilitating neurological diseases.
Career Highlights
Throughout his career, Ko has made notable strides in the biotechnology sector, having worked with esteemed organizations such as Valted, LLC and The Johns Hopkins University. His work in these innovative environments has enabled him to develop transformative solutions that address crucial health challenges. The experience gained from these institutes has allowed him to shape his vision towards pioneering medical advancements.
Collaborations
In his professional journey, Han Seok Ko has collaborated with esteemed colleagues such as Ted M. Dawson and Valina L. Dawson. These collaborations have fostered a rich environment for innovation and have significantly contributed to the progression of his research and development efforts.
Conclusion
Han Seok Ko exemplifies the spirit of innovation within the realm of medical science. His work on long-acting GLP-1 receptor agonists demonstrates his dedication to finding solutions for neurodegenerative diseases, showcasing the potential rewards of collaborative research and development. With ongoing research and potential future patents, Ko continues to inspire and influence the field of neuroscience.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile